CSIMarket
 
Brainstorm Cell Therapeutics inc   (BCLI)
 

Brainstorm Cell Therapeutics Inc's Customers Performance

BCLI



 
BCLI's Source of Revenues

List of BCLI Customers




for the same period Brainstorm Cell Therapeutics Inc

List of BCLI Customers

Brainstorm Cell Therapeutics Inc's Business Units






Brainstorm Cell Therapeutics Inc's Comment on Sales, Marketing and Customers



The company provides stem cell therapies to customers who seek reimbursement from government programs, including Medicare, and other third-party payors. These customers may experience challenges, reductions, or denials of reimbursement. The company encounters pricing pressures from managed healthcare organizations, managed care entities, and legislative proposals. Third-party payors frequently require pre-approval for coverage and negotiate predetermined discounts from list prices. The COVID-19 pandemic has led to a loss of employer-based insurance coverage, which may affect commercialization efforts. In the European Union, governments regulate pharmaceutical pricing through pricing and reimbursement policies and control of national healthcare systems.





Brainstorm Cell Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company provides stem cell therapies to customers who seek reimbursement from government programs, including Medicare, and other third-party payors. These customers may experience challenges, reductions, or denials of reimbursement. The company encounters pricing pressures from managed healthcare organizations, managed care entities, and legislative proposals. Third-party payors frequently require pre-approval for coverage and negotiate predetermined discounts from list prices. The COVID-19 pandemic has led to a loss of employer-based insurance coverage, which may affect commercialization efforts. In the European Union, governments regulate pharmaceutical pricing through pricing and reimbursement policies and control of national healthcare systems.








BCLI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Brainstorm Cell Therapeutics inc 11.37 0.00 -9.57 20
SUBTOTAL 0.00 0.00 0.00 -

Sources: Brainstorm Cell Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Brainstorm Cell Therapeutics inc’s corporate clients.
For your research, we’ve provided 9 tables on Brainstorm Cell Therapeutics inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.